PROVECTUS BIOPHARMACEUTICA-A PVCT
$0.07
-1.4% 52w: $0.04 – $0.10
Latest 13F among current holders filed 1 month ago (May 15, 2026)
Price — last 12 months
research preview data0.040.070.10
Jun 20, 2025 Jul 2, 2026
Institutional holders
6
+1 QoQ
13F value
$10K
+1.4% QoQ
Smart-money holders
1
signal tier ≥ 2
New smart buyers
0
Q1 2026
Institutional value by quarter
Number of holders
Who owns PVCT?
Q1 2026 filings| Fund | Type | Shares | Value | % of fund | Change |
|---|---|---|---|---|---|
| HOME FEDERAL BANK OF TENNESSEE | Wealth advisor | 100.0K | $5K | 0.0% | Held |
| Wealth Preservation Advisors, LLC | Other | 52.6K | $3K | 0.0% | Held |
| ACADEMY CAPITAL MANAGEMENT ★3 | Fundamental concentrated | 20.0K | $1K | 0.0% | Held |
| Atlas Wealth LLC | Other | 19.6K | $999 | 0.0% | New |
| Financial Symmetry Inc | Wealth advisor | 10.2K | $581 | 0.0% | Held |
| HUNTINGTON NATIONAL BANK | Diversified mechanical | 1 | $0 | 0.0% | Held |
Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.
Explore related
Top funds holding PVCT
More healthcare stocks held by institutions